Annual Shareholders Equity
$17.00 M
-$19.23 M-53.08%
31 December 2023
Summary:
Chemomab Therapeutics annual stockholders equity is currently $17.00 million, with the most recent change of -$19.23 million (-53.08%) on 31 December 2023. During the last 3 years, it has risen by +$6.20 million (+57.35%). CMMB annual shareholders equity is now -72.35% below its all-time high of $61.47 million, reached on 31 December 2021.CMMB Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$16.32 M
+$6.33 M+63.43%
01 September 2024
Summary:
Chemomab Therapeutics quarterly stockholders equity is currently $16.32 million, with the most recent change of +$6.33 million (+63.43%) on 01 September 2024. CMMB quarterly shareholders equity is now -76.02% below its all-time high of $68.04 million, reached on 30 June 2021.CMMB Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMMB Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -53.1% | - |
| 3 y3 years | +57.4% | -75.1% |
| 5 y5 years | - | - |
CMMB Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -72.3% | +57.4% | -75.1% | +63.4% |
| 5 y | 5 years | -72.3% | +57.4% | -76.0% | +63.4% |
| alltime | all time | -72.3% | +57.4% | -76.0% | +63.4% |
Chemomab Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $16.32 M(+63.4%) |
| June 2024 | - | $9.98 M(-25.1%) |
| Mar 2024 | - | $13.33 M(-21.6%) |
| Dec 2023 | $17.00 M(-53.1%) | $17.00 M(-22.7%) |
| June 2023 | - | $21.99 M(-21.3%) |
| Mar 2023 | - | $27.95 M(-22.8%) |
| Dec 2022 | $36.22 M | $36.22 M(-18.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $44.62 M(-13.9%) |
| June 2022 | - | $51.84 M(-9.4%) |
| Mar 2022 | - | $57.24 M(-6.9%) |
| Dec 2021 | $61.47 M(+469.0%) | $61.47 M(-6.2%) |
| Sept 2021 | - | $65.51 M(-3.7%) |
| June 2021 | - | $68.04 M(+23.3%) |
| Mar 2021 | - | $55.16 M(+410.7%) |
| Dec 2020 | $10.80 M | $10.80 M |
FAQ
- What is Chemomab Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual shareholders equity year-on-year change?
- What is Chemomab Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Chemomab Therapeutics?
What is Chemomab Therapeutics annual stockholders equity?
The current annual shareholders equity of CMMB is $17.00 M
What is the all time high annual shareholders equity for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual stockholders equity is $61.47 M
What is Chemomab Therapeutics annual shareholders equity year-on-year change?
Over the past year, CMMB annual stockholders equity has changed by -$19.23 M (-53.08%)
What is Chemomab Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CMMB is $16.32 M
What is the all time high quarterly shareholders equity for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly stockholders equity is $68.04 M